Blockade of mPT‐induced PD‐L1 achieves synergistic anti-TNBC efficacy by taking the intrinsic survival edge off the tumor cells on one hand and taking the brakes off the M1-like TAMs on the other. Here, CD274 is linked to neoplasm.